C.H. Robinson Declares Quarterly Cash Dividend
Get Alerts CHRW Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.4%
EPS Growth %: +17.8%
Join SI Premium – FREE
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- C.H. Robinson Worldwide, Inc. (“C.H. Robinson”) (Nasdaq: CHRW) announced that its Board of Directors today declared a regular quarterly cash dividend of 61 cents ($0.61) per share, payable on April 1, 2024, to shareholders of record on March 1, 2024.
C.H. Robinson has distributed uninterrupted dividends that have increased annually on a per share basis for twenty-five years. As of February 6, 2024, there were approximately 116,865,085 shares outstanding.
About C.H. Robinson
C.H. Robinson solves logistics problems for companies across the globe and across industries, from the simple to the most complex. With $22 billion in freight under management and 19 million shipments annually, we are one of the world’s largest logistics platforms. Our global suite of services accelerates trade to seamlessly deliver the products and goods that drive the world’s economy. With the combination of our multimodal transportation management system and expertise, we use our information advantage to deliver smarter solutions for our more than 90,000 customers and 450,000 contract carriers on our platform. Our technology is built by and for supply chain experts to bring faster, more meaningful improvements to our customers’ businesses. As a responsible global citizen, we are also proud to contribute millions of dollars to support causes that matter to our company, our Foundation and our employees. For more information, visit us at www.chrobinson.com (Nasdaq: CHRW).
CHRW-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20240207247772/en/
Chuck Ives, Director of Investor Relations
Email: [email protected]
Source: C.H. Robinson
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ISC2026: KAYTUS Launches Gigawatt-Scale Prefabricated AI Factory Data Center
- Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S.
- Nano One and Worley Chemetics Complete One-Pot(TM) LFP Cathode Package and Advance to Market
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share